Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 131,029 shares of the business’s stock in a transaction that occurred on Thursday, March 30th. The shares were sold at an average price of $17.00, for a total value of $2,227,493.00. Following the completion of the transaction, the chief financial officer now owns 147,778 […]
Related Keywords
San Diego , California , United States , Blackrock , Roth Mkm , Greg Zante , Raymond James , Michaela Dinerman , Therapeutics Inc , Nasdaq , Boxer Capital , Vanguard Group Inc , Blackrock Inc , Balyasny Asset Management , Dimensional Fund Advisors , Viking Therapeutics , Get Rating , Asset Management , Fund Advisors , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Vktx , Medical , Insider Trading , Nsider Trades , Stocks ,
vimarsana.com © 2020. All Rights Reserved.